James A. Warneke, MD, FACS, is a professor in the Department of Surgery, Division of General Surgery. He joined the faculty at the University of Arizona's College of Medicine in the Department of Surgery, Section of Surgical Oncology in 1991.
From 1992-2002, Dr. Warneke was the medical student clerkship director and then served as the residency director from 2001-2009. Before joining the Department of Surgery here at the University of Arizona, he was an assistant professor at the State University of New York. Dr. Warneke completed a surgical oncology fellowship at the Roswell Park Cancer Institute in Buffalo, NY. He completed his residency in general surgery at the University of Arizona. Dr. Warneke earned his Bachelor of Science with honors in biomedical sciences at the University of California in Riverside, California.
Dr. Warneke is involved in various research endeavors that allow him to continue to provide his patients with the most up-to-date treatment options available. Dr. Warneke’s research involves the treatment of skin malignancies, especially melanoma and sarcoma. His other research, conducted in the laboratory, consists of examining thymocyte receptor expression in melanoma, which is used to study the progression and prevention of melanoma. He is also co-principal investigator on a program project grant for the study of chemoprevention of skin cancer from the National Cancer Institute belonging to David Alberts, MD. Dr. Warneke is also a co-investigator on several Arizona Cancer Center clinical gene therapy studies funded by Vical, Inc. and coordinated by Evan Hersh, MD.
Skin malignancies, especially melanoma and sarcoma
Thymocyte receptor expression in melanoma
Chemoprevention of skin cancer